Guelph, Canada

Gabrielle Richard

This inventor holds 2 USPTO granted patents, plus 3 CIPO patents. Top assignee: University of Guelph. Active years: 2013-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabrielle Richard. Retrieved from https://idiyas.com/inventor/gabrielle-richard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Guleph, CA (2013)
  • Guelph, CA (2014)

Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gabrielle Richard: Innovator in Antibody Fragment Technology

Introduction

Gabrielle Richard is a prominent inventor based in Guelph, Canada. She has made significant contributions to the field of immunology, particularly in the development of antibody fragments. With a total of 2 patents, her work has the potential to impact various applications in medical research and treatment.

Latest Patents

Gabrielle Richard's latest patents include innovative methods for constructing a VH library from immunized camelids. One of her patents describes a method using whole venom or an extract thereof. This patent also provides VH antibody fragments isolated from a library produced in hyperimmunized llamas. These VH antibody fragments have been sequenced and are specifically designed to bind to α-cobratoxin.

Career Highlights

Gabrielle Richard is affiliated with the University of Guelph, where she continues her research and development in antibody technology. Her work is recognized for its potential to advance therapeutic options in various medical fields.

Collaborations

Some of her notable coworkers include J Christopher Hall and Michael D McLean. Their collaborative efforts contribute to the innovative research environment at the University of Guelph.

Conclusion

Gabrielle Richard is a trailblazer in the field of antibody fragment technology, with her patents paving the way for future advancements in immunology. Her contributions are invaluable to the scientific community and hold promise for medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…